NATURE . COM {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Nature.com Make Money
How Much Does Nature.com Make
Keywords
Topics
Questions
Schema
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We are analyzing https://www.nature.com/articles/nrn2598.

Title:
Prenatal exposure to drugs: effects on brain development and implications for policy and education | Nature Reviews Neuroscience
Description:
Exposurein uteroto drugs that modulate neurotransmitter systems present during early development can affect brain architecture and function. Levitt and colleagues consider what science has discovered about the effects of prenatal drug exposure and how this knowledge might influence public policy. The effects of prenatal exposure to drugs on brain development are complex and are modulated by the timing, dose and route of drug exposure. It is difficult to assess these effects in clinical cohorts as these are beset with problems such as multiple exposures and difficulties in documenting use patterns. This can lead to misinterpretation of research findings by the general public, the media and policy makers, who may mistakenly assume that the legal status of a drug correlates with its biological impact on fetal brain development and long-term clinical outcomes. It is important to close the gap between what science tells us about the impact of prenatal drug exposure on the fetus and the mother and what we do programmatically with regard to at-risk populations.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

Education
Family & Parenting
Science

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month

Based on our best estimate, this website will receive around 42,554,915 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)

google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)

conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$536,300 per month
Our analysis indicates Nature.com generates between $357,503 and $983,134 monthly online from display ads.

Keywords {🔍}

pubmed, google, scholar, cas, exposure, prenatal, brain, development, cocaine, res, effects, pregnancy, neurosci, central, cortex, nature, levitt, fetal, methamphetamine, drug, nicotine, rat, psychiatry, dopamine, behavioral, receptor, serotonin, ethanol, neuroscience, stanwood, health, access, neonatal, alcohol, developmental, neurotoxicol, teratol, children, cerebral, maternal, cell, child, drugs, pharmacol, dev, outcomes, rats, sci, exposed, exp,

Topics {✒️}

nature portfolio permissions reprints advertising transformative neurodevelopmental research national scientific council nature rev nature neurosci nature 416 nature author information authors research findings privacy policy regional beta2-adrenergic receptor activation research gaba-induced neurite outgrowth author correspondence springerlink instant access selective long-term dysfunction european economic area aid drug-exposed infants utero cocaine-induced dysfunction mpfc yanyan zheng central noradrenergic system transforming growth factor-β gabaa receptor activation permissions low-birth-weight children learning-related neuronal activity twelve-month neurofunctional assessment long-term clinical outcomes translating developmental time 16-year-olds prenatally exposed personal data brain-derived neurotrophic factor central executive component social media prenatal haloperidol induces data protection receptor tyrosine kinase nervous system development central auditory processing environmental tobacco smoke long-term developmental long-term adaptive long-term costs van de kar privacy serotonin1a receptor acts low birth weight

Questions {❓}

Does the use of nicotine replacement therapy during pregnancy affect pregnancy outcomes?
Fetal nicotine or cocaine exposure: which one is worse?
From oocyte to neuron: do neurotransmitters function in the same way throughout development?
If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Prenatal exposure to drugs: effects on brain development and implications for policy and education
         description:Exposurein uteroto drugs that modulate neurotransmitter systems present during early development can affect brain architecture and function. Levitt and colleagues consider what science has discovered about the effects of prenatal drug exposure and how this knowledge might influence public policy. The effects of prenatal exposure to drugs on brain development are complex and are modulated by the timing, dose and route of drug exposure. It is difficult to assess these effects in clinical cohorts as these are beset with problems such as multiple exposures and difficulties in documenting use patterns. This can lead to misinterpretation of research findings by the general public, the media and policy makers, who may mistakenly assume that the legal status of a drug correlates with its biological impact on fetal brain development and long-term clinical outcomes. It is important to close the gap between what science tells us about the impact of prenatal drug exposure on the fetus and the mother and what we do programmatically with regard to at-risk populations.
         datePublished:2009-03-11T00:00:00Z
         dateModified:2009-03-11T00:00:00Z
         pageStart:303
         pageEnd:312
         sameAs:https://doi.org/10.1038/nrn2598
         keywords:
            Biomedicine
            general
            Neurosciences
            Behavioral Sciences
            Biological Techniques
            Neurobiology
            Animal Genetics and Genomics
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnrn2598/MediaObjects/41583_2009_Article_BFnrn2598_Fig1_HTML.jpg
         isPartOf:
            name:Nature Reviews Neuroscience
            issn:
               1471-0048
               1471-003X
            volumeNumber:10
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Barbara L. Thompson
               affiliation:
                     name:Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.
                     address:
                        name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pat Levitt
               affiliation:
                     name:Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.
                     address:
                        name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Gregg D. Stanwood
               affiliation:
                     name:Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.
                     address:
                        name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Prenatal exposure to drugs: effects on brain development and implications for policy and education
      description:Exposurein uteroto drugs that modulate neurotransmitter systems present during early development can affect brain architecture and function. Levitt and colleagues consider what science has discovered about the effects of prenatal drug exposure and how this knowledge might influence public policy. The effects of prenatal exposure to drugs on brain development are complex and are modulated by the timing, dose and route of drug exposure. It is difficult to assess these effects in clinical cohorts as these are beset with problems such as multiple exposures and difficulties in documenting use patterns. This can lead to misinterpretation of research findings by the general public, the media and policy makers, who may mistakenly assume that the legal status of a drug correlates with its biological impact on fetal brain development and long-term clinical outcomes. It is important to close the gap between what science tells us about the impact of prenatal drug exposure on the fetus and the mother and what we do programmatically with regard to at-risk populations.
      datePublished:2009-03-11T00:00:00Z
      dateModified:2009-03-11T00:00:00Z
      pageStart:303
      pageEnd:312
      sameAs:https://doi.org/10.1038/nrn2598
      keywords:
         Biomedicine
         general
         Neurosciences
         Behavioral Sciences
         Biological Techniques
         Neurobiology
         Animal Genetics and Genomics
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnrn2598/MediaObjects/41583_2009_Article_BFnrn2598_Fig1_HTML.jpg
      isPartOf:
         name:Nature Reviews Neuroscience
         issn:
            1471-0048
            1471-003X
         volumeNumber:10
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Barbara L. Thompson
            affiliation:
                  name:Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.
                  address:
                     name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pat Levitt
            affiliation:
                  name:Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.
                  address:
                     name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Gregg D. Stanwood
            affiliation:
                  name:Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.
                  address:
                     name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature Reviews Neuroscience
      issn:
         1471-0048
         1471-003X
      volumeNumber:10
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.
      address:
         name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
         type:PostalAddress
      name:Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.
      address:
         name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
         type:PostalAddress
      name:Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.
      address:
         name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Barbara L. Thompson
      affiliation:
            name:Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.
            address:
               name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
               type:PostalAddress
            type:Organization
      name:Pat Levitt
      affiliation:
            name:Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.
            address:
               name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Gregg D. Stanwood
      affiliation:
            name:Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.
            address:
               name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
      name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
      name:Pat Levitt and Gregg D. Stanwood are at the Department of Pharmacology, Barbara L. Thompson, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37232, USA.,
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

Social Networks {👍}(2)

External Links {🔗}(433)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Prism.js
Zoom.js

Emails and Hosting {✉️}

Mail Servers:

mxa-002c5801.gslb.pphosted.com
mxb-002c5801.gslb.pphosted.com

Name Servers:

pdns1.ultradns.net
pdns2.ultradns.net
pdns3.ultradns.org
pdns4.ultradns.org
pdns5.ultradns.info
pdns6.ultradns.co.uk

CDN Services {📦}

Crossref

6.14s.